PE
BSX icon

Point72 Europe’s Boston Scientific BSX Stock Holding History

Point72 Europe’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$577K Buy
+5,910
New +$612K 0.03% 145
2024
Q1 		– Sell
-139,667
Closed -$8.07M – 154
2023
Q4 		$8.07M Sell
139,667
-166,126
-54% -$8.87M 1.01% 32
2023
Q3 		$16.1M Buy
305,793
+258,880
+552% +$13.6M 0.99% 10
2023
Q2 		$2.54M Buy
+46,913
New +$2.45M 0.33% 74

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Europe's BSX Position: Q3 2025 in Review

Point72 Europe opened a new position in Boston Scientific (BSX) in Q3 2025: 5,910 shares worth $577K. The stake represents 0.03% of the portfolio and ranks #145 among its holdings. This is a return to the name: Point72 Europe previously reported a position in BSX as recently as Q4 2023.

Point72 Europe first reported a position in BSX in Q2 2023 and has held it in 4 quarters since. The position peaked at $16.1M in Q3 2023. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Point72 Europe held 5,910 shares of Boston Scientific worth $577K as of Q3 2025.
  • Boston Scientific was a new Point72 Europe position in Q3 2025.
  • Boston Scientific made up 0.03% of Point72 Europe's portfolio in Q3 2025, its #145 holding.
  • Point72 Europe first reported a position in Boston Scientific in Q2 2023 and has held it in 4 quarters since.
  • Point72 Europe's Boston Scientific position peaked at $16.1M in Q3 2023.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.